|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Guardant Health, Inc. (GH) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
121,380,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0 - $0 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Guardant Health is a precision oncology company focused on helping conquer cancer globally through use of its proprietary blood-based tests, data sets and analytics. Co. is engaged in the clinical liquid biopsy market with its Guardant360 and GuardantOMNI tests. Co.'s Guardant360 test is a molecular diagnostic test measuring a number of cancer-related genes and its GuardantOMNI test has a 500-gene panel, both of which analyze circulating tumor DNA in blood. In addition, Co. is developing tests from its LUNAR-1 program for minimal residual disease and recurrence detection in cancer survivors, and its LUNAR-2 program for early detection of cancer.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
2,187 |
2,187 |
98,220 |
| Total Buy Value |
$0 |
$38,963 |
$38,963 |
$2,585,297 |
| Total People Bought |
0 |
1 |
1 |
2 |
| Total Buy Transactions |
0 |
1 |
1 |
4 |
| Total Shares Sold |
100 |
200 |
8,325 |
31,716 |
| Total Sell Value |
$2,787 |
$4,692 |
$233,035 |
$1,293,892 |
| Total People Sold |
1 |
1 |
2 |
3 |
| Total Sell Transactions |
1 |
2 |
6 |
12 |
| End Date |
2024-03-28 |
2023-12-26 |
2023-06-27 |
2022-06-27 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Lanman Richard B. |
Chief Medical Officer |
• – – |
2019-11-01 |
4 |
OE |
$4.18 |
$40,074 |
D/D |
5,764 |
87,779 |
|
- |
|
| Meresman Stanley J |
Director |
– • – |
2019-10-29 |
4 |
AS |
$70.34 |
$703,400 |
D/D |
(10,000) |
1,302 |
|
- |
|
| Meresman Stanley J |
Director |
– • – |
2019-10-29 |
4 |
OE |
$5.94 |
$59,400 |
D/D |
10,000 |
11,302 |
|
- |
|
| Clark Ian T |
Director |
– • – |
2019-10-28 |
4 |
AS |
$70.00 |
$225,960 |
D/D |
(3,228) |
1,302 |
|
- |
|
| Clark Ian T |
Director |
– • – |
2019-10-28 |
4 |
OE |
$4.18 |
$13,493 |
D/D |
3,228 |
4,530 |
|
- |
|
| Meresman Stanley J |
Director |
– • – |
2019-10-22 |
4 |
AS |
$66.60 |
$669,036 |
D/D |
(10,000) |
1,302 |
|
- |
|
| Meresman Stanley J |
Director |
– • – |
2019-10-22 |
4 |
OE |
$5.94 |
$59,400 |
D/D |
10,000 |
11,302 |
|
- |
|
| Wiley Michael J |
Chief Legal Officer |
• – – |
2019-10-10 |
4 |
GA |
$0.00 |
$0 |
I/I |
40,000 |
10,000 |
|
- |
|
| Wiley Michael J |
Chief Legal Officer |
• – – |
2019-10-10 |
4 |
GD |
$0.00 |
$0 |
D/D |
40,000 |
172,737 |
|
- |
|
| Clark Ian T |
Director |
– • – |
2019-09-25 |
4 |
AS |
$72.00 |
$38,736 |
D/D |
(538) |
1,302 |
|
- |
|
| Clark Ian T |
Director |
– • – |
2019-09-25 |
4 |
OE |
$4.18 |
$2,249 |
D/D |
538 |
1,840 |
|
- |
|
| Meresman Stanley J |
Director |
– • – |
2019-09-24 |
4 |
AS |
$73.67 |
$736,948 |
D/D |
(10,000) |
1,302 |
|
- |
|
| Meresman Stanley J |
Director |
– • – |
2019-09-24 |
4 |
OE |
$5.94 |
$59,400 |
D/D |
10,000 |
11,302 |
|
- |
|
| Wiley Michael J |
Chief Legal Officer |
• – – |
2019-09-17 |
4 |
OE |
$4.18 |
$16,720 |
D/D |
4,000 |
212,737 |
|
- |
|
| Meresman Stanley J |
Director |
– • – |
2019-09-17 |
4 |
AS |
$74.89 |
$753,801 |
D/D |
(10,000) |
1,302 |
|
- |
|
| Meresman Stanley J |
Director |
– • – |
2019-09-17 |
4 |
OE |
$5.94 |
$59,400 |
D/D |
10,000 |
11,302 |
|
- |
|
| Meresman Stanley J |
Director |
– • – |
2019-09-12 |
4 |
AS |
$75.54 |
$763,633 |
D/D |
(10,000) |
1,302 |
|
- |
|
| Meresman Stanley J |
Director |
– • – |
2019-09-12 |
4 |
OE |
$5.94 |
$59,400 |
D/D |
10,000 |
11,302 |
|
- |
|
| Kaul Samir |
Director |
– • – |
2019-09-11 |
4 |
GD |
$0.00 |
$0 |
I/I |
13,754 |
1,405 |
|
- |
|
| Svf Endurance (cayman) Ltd |
10% Owner |
– – • |
2019-09-11 |
4 |
S |
$77.00 |
$377,300,000 |
D/D |
(4,900,000) |
22,950,460 |
|
- |
|
| Talasaz Amirali |
Chairman, President and COO |
• • – |
2019-09-06 |
4 |
OE |
$4.18 |
$299,994 |
D/D |
71,769 |
73,223 |
|
- |
|
| Eltoukhy Helmy |
Chief Executive Officer |
• • – |
2019-09-06 |
4 |
OE |
$4.18 |
$299,994 |
D/D |
71,769 |
3,596,334 |
|
- |
|
| Clark Ian T |
Director |
– • – |
2019-09-03 |
4 |
AS |
$85.70 |
$230,533 |
D/D |
(2,690) |
1,302 |
|
- |
|
| Clark Ian T |
Director |
– • – |
2019-09-03 |
4 |
OE |
$4.18 |
$11,244 |
D/D |
2,690 |
3,992 |
|
- |
|
| Hilaly Aaref |
Director |
– • – |
2019-08-29 |
4 |
A |
$0.00 |
$0 |
I/I |
16,373 |
49,119 |
|
- |
|
707 Records found
|
|
Page 24 of 29 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
